Brian Khong, DO
Endocrinology · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health Ukiah Valley · Sutter Lakeside Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Khong’s office at (415) 600-1020 to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
- Sutter Lakeside HospitalLakeport, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sutter Lakeside Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.7 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 379 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 31 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.249 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -25.4 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -37.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.3) · 564 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (209 patients answered, 18% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$319,685
Medicare paid this office $319,685 for 480 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 61 | $112,324 | None |
| Return visit (30+ min) | 388 | $70,963 | $100 |
| Long return visit (40+ min) | 83 | $12,410 | $125 |
| New patient visit (45+ min) | 86 | $9,903 | $115 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 376 | $8,123 | $13 |
See all 10 services
| Injection, denosumab, 1 mg | 61 | $112,324 | None |
| Return visit (30+ min) | 388 | $70,963 | $100 |
| Long return visit (40+ min) | 83 | $12,410 | $125 |
| New patient visit (45+ min) | 86 | $9,903 | $115 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 376 | $8,123 | $13 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 63 | $3,602 | $28 |
| New patient visit (60+ min) | 15 | $2,813 | $188 |
| Injection of drug or substance under skin or into muscle | 74 | $2,643 | $13 |
| Short return visit (20+ min) | 27 | $2,484 | $65 |
| Hemoglobin a1c level | 66 | $885 | $10 |
Who their Medicare patients are
480 Original Medicare patients in 2024. Average age 74 · Under 65 4% · 85 and older 8% · Women 79% · Also on Medicaid 13% · Health risk score 1.21. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 54% · Diabetes 31% · Chronic kidney disease 28% · Coronary heart disease 18% · Depression 18% · Atrial fibrillation 16% · Cancer 15% · Heart failure 11% · COPD 9% · Stroke 6% · Dementia 4%.
The office billed $999,380, Medicare allowed $418,579 and paid $319,685; for 19,135 services of 19 kinds; $204,014 of it was for drugs given in the office and $115,672 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 480 | 19,135 | 74 | 1.21 | $999,380 | $319,685 |
| 2023 | 255 | 3,942 | 74 | 1.26 | $235,883 | $85,469 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Injection, denosumab, 1 mg | 31 | $34,176 | None |
| Return visit (30+ min) | 134 | $15,091 | $109 |
| Long return visit (40+ min) | 96 | $14,528 | $148 |
| New patient visit (45+ min) | 19 | $2,637 | $139 |
| New patient visit (60+ min) | 13 | $2,442 | $188 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 36 | $1,125 | $29 |
| Injection of drug or substance under skin or into muscle | 36 | $601 | $13 |
| Hemoglobin a1c level | 32 | $324 | $10 |
Medicaid work
$3,037 in 2024
Medicaid paid $3,037 for 103 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 103 | $3,037 |
| 2024 | 103 | 1 | 18 | $3,037 |
| 2023 | 13 | 1 | 13 | $439 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 13 | $439 |
Drugs they prescribed that Part D paid
$1,045,783
Pharmacies billed $1,045,783 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,104) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
994 generic and 986 brand-name prescriptions · $1,045,783 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 194 | $274,358 | $1,414 |
| Jardiance | 95 | $133,234 | $1,402 |
| Trulicity | 93 | $124,948 | $1,344 |
| Mounjaro | 69 | $83,557 | $1,211 |
| Humalog Kwikpen U-200 | 20 | $37,746 | $1,887 |
See all 41 drugs
| Ozempic | 194 | $274,358 | $1,414 |
| Jardiance | 95 | $133,234 | $1,402 |
| Trulicity | 93 | $124,948 | $1,344 |
| Mounjaro | 69 | $83,557 | $1,211 |
| Humalog Kwikpen U-200 | 20 | $37,746 | $1,887 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | 16 | $36,021 | $2,251 |
| Evenity (2 Syringes) | 13 | $31,003 | $2,385 |
| Prolia | 17 | $28,263 | $1,663 |
| Wegovy | 14 | $21,241 | $1,517 |
| Fiasp Flextouch | 17 | $15,839 | $932 |
| Jatenzo | 11 | $15,560 | $1,415 |
| Tresiba Flextouch U-100 | 18 | $12,244 | $680 |
| Lantus Solostar | 77 | $10,940 | $142 |
| Tradjenta | 15 | $10,667 | $711 |
| Humalog Kwikpen U-100 | 29 | $9,915 | $342 |
| Humalog | 17 | $6,835 | $402 |
| V-Go 40 | 12 | $6,067 | $506 |
| Novolog Flexpen | 17 | $4,531 | $267 |
| Cinacalcet | 39 | $4,425 | $113 |
| Synthroid | 54 | $3,616 | $67 |
| Levothyroxine | 284 | $3,421 | $12 |
| Ultra-Fine Mini Pen Needle | 22 | $2,843 | $129 |
| Hydrocortisone | 24 | $1,840 | $77 |
| Testosterone | 27 | $1,593 | $59 |
| Insulin Lispro | 17 | $1,301 | $77 |
| Testosterone Cypionate | 33 | $1,239 | $38 |
| Liothyronine | 19 | $1,111 | $58 |
| Atorvastatin | 65 | $802 | $12 |
| Armour Thyroid | 20 | $801 | $40 |
| Risedronate | 14 | $800 | $57 |
| Metformin Hcl Er | 58 | $781 | $13 |
| Methimazole | 87 | $739 | $8 |
| Metformin | 56 | $636 | $11 |
| Alendronate | 76 | $527 | $7 |
| Fenofibrate | 11 | $342 | $31 |
| Simvastatin | 19 | $251 | $13 |
| Lisinopril | 12 | $173 | $14 |
| Gabapentin | 11 | $156 | $14 |
| Glipizide | 13 | $140 | $11 |
| Hydrochlorothiazide | 31 | $128 | $4 |
| Amlodipine Besylate | 12 | $30 | $3 |
Year by year
| 2024 | 2,104 | 373 | 0% (0) | 47% | $1,045,783 |
| 2023 | 1,100 | 251 | 0% (0) | 58% | $836,069 |
| 2022 | 485 | 93 | 0% (0) | 53% | $272,547 |
| 2021 | 143 | 36 | 0% (0) | None | $54,256 |
| 2020 | 56 | 21 | 0% (0) | None | $6,832 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Trulicity | 86 | $160,643 | $1,868 |
| Ozempic | 80 | $112,526 | $1,407 |
| Lantus Solostar | 105 | $78,929 | $752 |
| Jardiance | 57 | $75,737 | $1,329 |
| Victoza 3-Pak | 25 | $73,016 | $2,921 |
| Novolog Flexpen | 33 | $41,996 | $1,273 |
| Humalog Kwikpen U-100 | 28 | $38,448 | $1,373 |
| Tradjenta | 24 | $32,321 | $1,347 |
| Humalog Kwikpen U-200 | 14 | $29,262 | $2,090 |
| Humalog | 11 | $18,407 | $1,673 |
| Tresiba Flextouch U-100 | 12 | $16,058 | $1,338 |
| Insulin Lispro Kwikpen U-100 | 15 | $3,552 | $237 |
| Ultra-Fine Mini Pen Needle | 19 | $2,885 | $152 |
| Insulin Aspart | 11 | $2,835 | $258 |
| Levothyroxine | 97 | $1,718 | $18 |
| Metformin Hcl Er | 42 | $1,521 | $36 |
| Atorvastatin | 53 | $795 | $15 |
| Synthroid | 15 | $778 | $52 |
| Acarbose | 12 | $389 | $32 |
| Methimazole | 31 | $373 | $12 |
| Metformin | 19 | $197 | $10 |
| Alendronate | 20 | $100 | $5 |
| Glipizide | 12 | $94 | $8 |
2022: 15 drugs
| Lantus Solostar | 66 | $66,107 | $1,002 |
| Ozempic | 20 | $33,477 | $1,674 |
| Humalog Kwikpen U-200 | 11 | $30,986 | $2,817 |
| Trulicity | 15 | $24,516 | $1,634 |
| Humalog Kwikpen U-100 | 17 | $22,932 | $1,349 |
| Tradjenta | 16 | $17,102 | $1,069 |
| Januvia | 17 | $15,138 | $890 |
| Insulin Lispro Kwikpen U-100 | 22 | $4,639 | $211 |
| Ultra-Fine Mini Pen Needle | 17 | $1,573 | $93 |
| Levothyroxine | 46 | $936 | $20 |
| Acarbose | 23 | $746 | $32 |
| Atorvastatin | 19 | $316 | $17 |
| Metformin Hcl Er | 18 | $209 | $12 |
| Methimazole | 14 | $144 | $10 |
| Alendronate | 11 | $4 | $0 |
2021: 1 drug
| Atorvastatin | 12 | $243 | $20 |
Money from drug and device companies
$15 in 2024
| 2024 | 1 | 1 | None | $15 |
| 2022 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Radius Health | Tymlos | $15 | 1 payment
|
See the published payment
| Radius Health | Education · 2024-03-06 | Tymlos | $15 |
See earlier years (2022)
2022: $15
| Xeris Pharmaceuticals | Gvoke Pfs | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1649765405
- Licence
- CA 20A17575
- Trained
- Touro Un College of Osteopathic Medicine, Vallejo, 2017
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2018-06-25
- NPI last updated
- 2024-11-15
- NPI record certified
- 2024-11-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1720 E Cesar E Chavez Ave, Los Angeles, CA, 90033